Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Regorafenib Treatment for Recurrent Glioblastoma Beyond Bevacizumab-Based Therapy: A Large, Multicenter, Real-Life Study.
Tünbekici S, Yuksel HC, Acar C, Sahin G, Orman S, Majidova N, Coskun A, Seyyar M, Dilek MS, Kara M, Dıslı AK, Demir T, Kolkıran N, Sahbazlar M, Demırcıler E, Kuş F, Aytac A, Menekse S, Yucel H, Biter S, Koseci T, Unsal A, Ozveren A, Sevınc A, Goker E, Gürsoy P. Tünbekici S, et al. Cancers (Basel). 2024 Dec 27;17(1):46. doi: 10.3390/cancers17010046. Cancers (Basel). 2024. PMID: 39796675 Free PMC article.
Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer.
Kınıkoğlu O, Odabas H, Altıntaş YE, Yıldız A, Çakan B, Akdağ G, Yıldırım S, Bal H, Kaya T, Tünbekici S, Işık D, Başoğlu T, Yıldırım ME, Turan N. Kınıkoğlu O, et al. Among authors: tunbekici s. Medicina (Kaunas). 2024 Jun 7;60(6):951. doi: 10.3390/medicina60060951. Medicina (Kaunas). 2024. PMID: 38929568 Free PMC article.
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy.
Yildirim S, Dogan A, Akdag G, Yüksel Yasar Z, Bal H, Kinikoglu O, Oksuz S, Ozkerim U, Tunbekici S, Yildiz HS, Alan O, Coban Kokten S, Isik D, Surmeli H, Basoglu T, Sever ON, Odabas H, Yildirim ME, Turan N. Yildirim S, et al. Among authors: tunbekici s. Sci Rep. 2024 May 27;14(1):12123. doi: 10.1038/s41598-024-63096-7. Sci Rep. 2024. PMID: 38802494 Free PMC article.
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status.
Akdag G, Yildirim S, Dogan A, Yuksel Yasar Z, Bal H, Kinikoglu O, Oksuz S, Ozkerim U, Tunbekici S, Yildiz HS, Turkoglu E, Alan O, Coban Kokten S, Isik D, Sever ON, Odabas H, Yildirim ME, Turan N. Akdag G, et al. Among authors: tunbekici s. Chemotherapy. 2024;69(3):141-149. doi: 10.1159/000537874. Epub 2024 Feb 16. Chemotherapy. 2024. PMID: 38368871